Matinas BioPharma Holdings (MTNB) Current Leases (2014 - 2026)
Matinas BioPharma Holdings (MTNB) reported Current Leases of $718000.0 for Q1 2026, up 11866.67% year-over-year from N/an in Q1 2025, and up 35800.0% quarter-over-quarter from $2000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Current Leases (2014 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 13 years of Current Leases data on file, last reported at $718000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $718000.0, up 11866.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $718000.0 (up 11866.67% YoY), and the FY2025 annual result was $2000.0, down 60.0% from the prior year.
- Current Leases advanced to $718000.0 in Q1 2026 per MTNB's latest filing, from $2000.0 in the prior quarter.
- Over five years, Current Leases peaked at $817000.0 in Q2 2025 and troughed at $2000.0 in Q4 2025.
- A 5-year average of $203989.5 and a median of $5000.0 in 2023 frame the typical range for Current Leases.
- On a YoY basis, Current Leases climbed as much as 16240.0% in 2025 and fell as far as 99.32% in 2025.
- A 5-year view of Current Leases shows it stood at $7000.0 in 2022, then fell by 28.57% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then sank by 60.0% to $2000.0 in 2025, then jumped by 35800.0% to $718000.0 in 2026.
- Business Quant data shows MTNB's Current Leases at $718000.0 in Q1 2026, $2000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | 718,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 718,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 817,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 733,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,860.00 |
| Jun 30, 2022 | 579,260.00 |
| Mar 31, 2022 | 558,702.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 24,309.00 |
| Jun 30, 2021 | 26,870.00 |